ÂÜÀòÂÒÂ×

Praveen Srivastava is an experienced professional in the pharmaceutical and biotech industries, currently serving as Senior Manager and Head of Development Bioanalytical at Nurix Therapeutics since July 2022. In this role, Praveen acts as the bioanalytical and DMPK representative for clinical and non-clinical projects targeting cancer treatments, managing outsourcing and vendor performance for bioanalytical studies. Prior experiences include roles at Spero Therapeutics, Alkermes, QPS Holdings, and Children's Hospital of Philadelphia, where Praveen focused on bioanalytical support and vendor management across various clinical studies. Praveen holds a Master’s degree in Pharmaceutical Chemistry from Fairleigh Dickinson University and a Bachelor's degree in Pharmacy from the Indian Institute of Technology (Banaras Hindu University). Additionally, Praveen completed a business administration program at Columbia Business School.